Benzoyl peroxide formulated polycarbophil/carbopol 934P hydrogel with selective antimicrobial activity, potentially beneficial for treatment and prevention of bacterial vaginosis

Infectious Diseases in Obstetrics and Gynecology

Volumn 2013, Issue , 2013, Pages

  Xu, Shiqi ^a   Cavera, Veronica L ^b   Rogers, Michael A ^a   Huang, Qingrong ^a   Zubovskiy, Konstantin ^c   Chikindas, Michael L ^a,d  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Scientelle LLC   (United States)

^d Bioronus LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID RESIN; ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; CARBOPOL 940; DRUG CARRIER; POLYCARBOPHIL CALCIUM;

ARTICLE; CHEMISTRY; DRUG EFFECT; FEMALE; GARDNERELLA VAGINALIS; GRAM POSITIVE INFECTION; HUMAN; HYDROGEL; LACTOBACILLUS; MICROBIAL SENSITIVITY TEST; VAGINITIS;

ACRYLIC RESINS; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; DRUG CARRIERS; FEMALE; GARDNERELLA VAGINALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; HYDROGEL; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; VAGINOSIS, BACTERIAL;

EID: 84893759119     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2013/909354     Document Type: Article

References (34)

1. Swidsinski A., Verstraelen H., Loening-Baucke V., Swidsinski S., Mendling W., Halwani Z., Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PloS ONE 2013 8 1 e53997
2. Swidsinski A., Mendling W., Loening-Baucke V., Swidsinski S., Dörffel Y., Scholze J., Lochs H., Verstraelen H., An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. The American Journal of Obstetrics and Gynecology 2008 198 1 e1 e6 2-s2.0-37349022421 10.1016/j.ajog.2007.06.039 (Pubitemid 350309276)
3. Santiago G. L. D. S., Tency I., Verstraelen H., Trog M., Temmerman M., Vancoillie L., Decat E., Cools P., Vaneechoutte M., Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina. PloS ONE 2012 7 9 e45281
4. Menard J.-P., Fenollar F., Henry M., Bretelle F., Raoult D., Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clinical Infectious Diseases 2008 47 1 33 43 2-s2.0-46249125627 10.1086/588661 (Pubitemid 351920584)
5. Fredricks D. N., Fiedler T. L., Thomas K. K., Oakley B. B., Marrazzo J. M., Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. Journal of Clinical Microbiology 2007 45 10 3270 3276 2-s2.0-35348852708 10.1128/JCM.01272-07 (Pubitemid 47585650)
6. Biagi E., Vitali B., Pugliese C., Candela M., Donders G. G. G., Brigidi P., Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. European Journal of Clinical Microbiology and Infectious Diseases 2009 28 3 281 285 2-s2.0-61349127180 10.1007/s10096-008-0617-0
7. Srinivasan S., Hoffman N. G., Morgan M. T., Matsen F. A., Fiedler T. L., Hall R. W., Ross F. J., McCoy C. O., Bumgarner R., Marrazzo J. M., Fredricks D. N., Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PloS ONE 2012 7 6 e37818
8. Mitchell C., Manhart L. E., Thomas K., Fiedler T., Fredricks D. N., Marrazzo J., Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study. Infectious Diseases in Obstetrics and Gynecology 2012 2012 6 706540 10.1155/2012/706540
9. Eschenbach D. A., Davick P. R., Williams B. L., Klebanoff S. J., Young-Smith K., Critchlow C. M., Holmes K. K., Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. Journal of Clinical Microbiology 1989 27 2 251 256 2-s2.0-0024552487 (Pubitemid 19041152)
10. Bradshaw C. S., Vodstrcil L. A., Hocking J. S., Law M., Pirotta M., Garland S. M., De Guingand D., Morton A. N., Fairley C. K., Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clinical Infectious Diseases 2013 56 6 777 785
11. Hymes S. R., Randis T. M., Sun T. Y., Ratner A. J., DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo. Journal of Infectious Diseases 2013 207 10 1494 1497
12. Aroutcheva A., Gariti D., Simon M., Shott S., Faro J., Simoes J. A., Gurguis A., Faro S., Defense factors of vaginal lactobacilli. The American Journal of Obstetrics and Gynecology 2001 185 2 375 379 2-s2.0-0034888580 10.1067/mob.2001.115867 (Pubitemid 32769439)
13. Motevaseli E., Shirzad M., Raoofian R., Hasheminasab S. M., Hatami M., Dianatpour M., Modarressi M. H., Difference in vaginal lactobacilli composition of Iranian healthy and bacterial vaginosis infected women: a comparative analysis of their cytotoxic effects with commercial vaginal probiotics. Iranian Red Crescent Medical Journal 2013 15 3 199 206
14. Mart nez-Peña M., Castro-Escarpulli G., Aguilera-Arreola M. G., Lactobacillus species isolated from vaginal secretions of healthy and bacterial vaginosis-intermediate Mexican women: a prospective study. BMC Infectious Diseases 2013 13, article 189
15. World Health Orgnization, WHO model list of essential medicines adults 17th edition. 2011, http://www.who.int/medicines/publications/ essentialmedicines/en/index.html
16. Thakur N. K., Bharti P., Mahant S., Rao R., Formulation and characterization of benzoyl peroxide gellified emulsions. Scientia Pharmaceutica 2012 80 4 1045 1060
17. El-Samragy Y., Benzoyl peroxide chemical and technical assessment. Joint FAO/WHO Expert Committee on Food Additives, 61st meeting, 2004, http://www.fao.org/fileadmin/templates/agns/pdf/jecfa/cta/63/Benzoylperoxide.pdf
18. Nozaki K., Bartlett P. D., The kinetics of decomposition of benzoyl peroxide in solvents. I. Journal of the American Chemical Society 1946 68 9 1686 1692 2-s2.0-0003451399
19. das Neves J., Bahia M. F., Gels as vaginal drug delivery systems. International Journal of Pharmaceutics 2006 318 1-2 1 14 2-s2.0-33745504777 10.1016/j.ijpharm.2006.03.012 (Pubitemid 43963297)
20. Pendharkar S., Magopane T., Larsson P. G., de Bruyn G., Gray G. E., Hammarström L., Marcotte H., Identification and characterisation of vaginal lactobacilli from South African women. BMC Infectious Diseases 2013 13, article 43
21. Bilensoy E., Rouf M. A., Vural I., Şen M., Hincal A. A., Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β -cyclodextrin complex. AAPS PharmSciTech 2006 7 2, article 38 E54 E60 2-s2.0-33646180377
22. Owen D. H., Peters J. J., Katz D. F., Rheological properties of contraceptive gels. Contraception 2000 62 6 321 326 2-s2.0-0034484004 10.1016/S0010-7824(00)00184-0 (Pubitemid 32182420)
23. Owen D. H., Katz D. F., A vaginal fluid simulant. Contraception 1999 59 2 91 95 2-s2.0-0033023953 10.1016/S0010-7824(99)00010-4 (Pubitemid 29244754)
24. Waksman S. A., Reilly H. C., Agar-streak method for assaying antibiotic substances. Industrial and Engineering Chemistry 1945 17 9 556 558 2-s2.0-0040194589
25. Liang R., Xu S., Shoemaker C. F., Li Y., Zhong F., Huang Q., Physical and antimicrobial properties of peppermint oil nanoemulsions. Journal of Agricultural and Food Chemistry 2012 60 7548 7555
26. Herigstad B., Hamilton M., Heersink J., How to optimize the drop plate method for enumerating bacteria. Journal of Microbiological Methods 2001 44 2 121 129 2-s2.0-0035283754 10.1016/S0167-7012(00)00241-4 (Pubitemid 32124778)
27. Kim J.-Y., Song J.-Y., Lee E.-J., Park S.-K., Rheological properties and microstructures of Carbopol gel network system. Colloid and Polymer Science 2003 281 7 614 623 2-s2.0-0038044103 10.1007/s00396-002-0808-7 (Pubitemid 36889564)
28. das Neves J., da Silva M. V., Gonçalves M. P., Amaral M. H., Bahia M. F., Rheological properties of vaginal hydrophilic polymer gels. Current Drug Delivery 2009 6 1 83 92 2-s2.0-61849103596 10.2174/156720109787048294
29. U.S. Department of Health and Human Services, Food and Drug Administration and Center for Drug Evaluation and Research, Guidance for industry: topical acne drug products for over-the counter human use: revision of labeling and clssification of benzoyl peroxide as safe and effective. http://www.fda.gov/downloads/Drugs/Guidances/UCM259744.pdf
30. Consumer Healthcare Products Association, Dermal oncogenicity study of benzoyl peroxide gels in rats. http://www.fda.gov/ohrms/dockets/dailys/02/Aug02/ 081302/8001e97b.pdf
31. Lerche C. M., Philipsen P. A., Poulsen T., Wulf H. C., Photocarcinogenesis and toxicity of benzoyl peroxide in hairless mice after simulated solar radiation. Experimental Dermatology 2010 19 4 381 386 2-s2.0-77951755362 10.1111/j.1600-0625.2009.00927.x
32. Epstein J. H., Photocarcinogenesis promotion studies with benzoyl peroxide (BPO) and croton oil. Journal of Investigative Dermatology 1988 91 2 114 116 2-s2.0-0023805110
33. Papafragkou S., Gasparyan A., Batista R., Scott P., Treatment of portal venous gas embolism with hyperbaric oxygen after accidental ingestion of hydrogen peroxide: a case report and review of the literature. Journal of Emergency Medicine 2012 43 1 e21 e23 2-s2.0-70350029592 10.1016/j.jemermed.2009. 07.043
34. Slaga T. J., Klein-Szanto A. J. P., Triplett L. L., Yotti L. P., Trosko J. E., Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 1981 213 4511 1023 1025 2-s2.0-0019890232